15 completed. 9 Phase 2, 6 Phase 3.
By phase and status
Follow asoprisnil: new trials by email Literature Review of asoprisnil trials Research Report on asoprisnil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Study of Asoprisnil in the Treatment of Uterine Fibroids. Asoprisnil - Fibroid Uterus, Leiomyoma | Phase 3 | Completed | 149 | 2004-11-01 | 2008-05-28 |
Safety of Treatment of Uterine Fibroids With Asoprisnil Asoprisnil - Fibroid Uterus, Leiomyoma | Phase 3 | Completed | 166 | 2004-04-01 | 2008-05-29 |
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids Asoprisnil, Placebo - Fibroid Uterus, Leiomyoma | Phase 3 | Completed | 239 | 2003-09-01 | 2008-05-29 |
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Asoprisnil - Leiomyoma, Menorrhagia | Phase 3 | Completed | 523 | 2003-09-01 | 2008-05-29 |
A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy Asoprisnil, Placebo - Uterine Fibroids, Leiomyoma | Phase 2 | Completed | 33 | 2003-07-01 | 2008-05-29 |
A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398 Asoprisnil - Endometriosis | Phase 2 | Completed | 73 | 2002-12-01 | 2008-05-29 |
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids Asoprisnil, Placebo - Leiomyoma, Menorrhagia | Phase 3 | Completed | 432 | 2002-09-01 | 2008-05-29 |
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis. Asoprisnil, Placebo - Endometriosis | Phase 2 | Completed | 131 | 2002-08-01 | 2008-05-29 |
Treatment of Uterine Fibroids With Asoprisnil(J867) Asoprisnil, Placebo - Leiomyoma, Menorrhagia | Phase 3 | Completed | 475 | 2002-07-01 | 2008-05-29 |
Menorrhagia Study in Women With Treatment-resistant Menorrhagia Asoprisnil (BAY86-5294), Placebo - Menorrhagia | Phase 2 | Completed | 26 | 2001-11-01 | 2014-12-30 |
A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Asoprisnil - Leiomyoma | Phase 2 | Completed | 38 | 2001-04-01 | 2009-03-04 |
A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women Asoprisnil/Premarin - Postmenopause | Phase 2 | Completed | 18 | 2001-04-01 | 2008-05-29 |
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women Asoprisnil/Premarin, Placebo and Premarin - Amenorrhea, Postmenopause | Phase 2 | Completed | 105 | 2000-09-01 | 2008-05-29 |
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids Asoprisnil, Placebo - Leiomyoma | Phase 2 | Completed | 129 | 2000-05-01 | 2008-05-29 |
A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis Asoprisnil, Placebo - Endometriosis | Phase 2 | Completed | 130 | 2000-05-01 | 2008-05-29 |
Conditions studied
Leiomyoma (9) · Menorrhagia (7) · Metrorrhagia (6) · Uterine Hemorrhage (6) · Dysmenorrhea (3) · Dyspareunia (3) · Endometriosis (3) · Infertility (3) · Pelvic Pain (3) · Amenorrhea (2)
Sponsors
Abbott (14) · Bayer (1)
Results publications
PMID 23188490, PMID 30865281, PMID 17307170, PMID 17339234, PMID 31777761